Evidence map›Paper›PMID 20195513›Full record

ArticlePLoS genetics2010

Cdk1 targets Srs2 to complete synthesis-dependent strand annealing and to promote recombinational repair.

Marco Saponaro, Devon Callahan, Xiuzhong Zheng, Lumir Krejci, James E Haber, Hannah L Klein, Giordano Liberi

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Marco SaponaroInstitute of Molecular Oncology Foundation, The Italian Foundation for Cancer Research and Dipartimento di Scienze Biomolecolari e Biotecnologie-University of Milan, Milan, Italy.
Devon Callahan
Xiuzhong Zheng
Lumir Krejci
James E Haber
Hannah L Klein
Giordano Liberi
Kaplan (United States) · USUniversity of Milan · ITBrandeis University · USMasaryk University · CZNew York University · US

Funding

Recombination Mechanisms in Yeast Cell DifferentiationR37GM020056 · NIGMS · BRANDEIS UNIVERSITY · PI HABER, JAMES E · 2007 to 2016
$5.5M
Arrest, Recovery, and Adaptation from DNA DamageR01GM061766 · NIGMS · BRANDEIS UNIVERSITY · PI HABER, JAMES E · 2001 to 2016
$4.6M
RECOMBINATION MECHANISMS IN YEAST CELL DIFFERENTIATIONR01GM020056 · NIGMS · BRANDEIS UNIVERSITY · PI HABER, JAMES E · 1985 to 2006
$3.4M
DNA HELICASES IN RECOMBINATION AND REPAIRR01GM053738 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KLEIN, HANNAH L. · 1997 to 2010
$2.4M
NIGMS NIH HHS GM20056NIGMS NIH HHS GM53738NIGMS NIH HHS GM61766NIGMS NIH HHS R01 GM020056NIGMS NIH HHS R01 GM053738NIGMS NIH HHS R01 GM061766NIGMS NIH HHS R37 GM020056
6 · The paper itself

Abstract

Cdk1 kinase phosphorylates budding yeast Srs2, a member of UvrD protein family, displays both DNA translocation and DNA unwinding activities in vitro. Srs2 prevents homologous recombination by dismantling Rad51 filaments and is also required for double-strand break (DSB) repair. Here we examine the biological significance of Cdk1-dependent phosphorylation of Srs2, using mutants that constitutively express the phosphorylated or unphosphorylated protein isoforms. We found that Cdk1 targets Srs2 to repair DSB and, in particular, to complete synthesis-dependent strand annealing, likely controlling the disassembly of a D-loop intermediate. Cdk1-dependent phosphorylation controls turnover of Srs2 at the invading strand; and, in absence of this modification, the turnover of Rad51 is not affected. Further analysis of the recombination phenotypes of the srs2 phospho-mutants showed that Srs2 phosphorylation is not required for the removal of toxic Rad51 nucleofilaments, although it is essential for cell survival, when DNA breaks are channeled into homologous recombinational repair. Cdk1-targeted Srs2 displays a PCNA-independent role and appears to have an attenuated ability to inhibit recombination. Finally, the recombination defects of unphosphorylatable Srs2 are primarily due to unscheduled accumulation of the Srs2 protein in a sumoylated form. Thus, the Srs2 anti-recombination function in removing toxic Rad51 filaments is genetically separable from its role in promoting recombinational repair, which depends exclusively on Cdk1-dependent phosphorylation. We suggest that Cdk1 kinase counteracts unscheduled sumoylation of Srs2 and targets Srs2 to dismantle specific DNA structures, such as the D-loops, in a helicase-dependent manner during homologous recombinational repair.

Indexed as

DNA RepairRecombination, GeneticCDC28 Protein Kinase, S cerevisiaeConsensus SequenceDNA Breaks, Double-StrandedDNA, FungalDNA HelicasesMicrobial ViabilityModels, BiologicalMutationPhosphorylationProliferating Cell Nuclear AntigenProtein BindingProtein Processing, Post-TranslationalRad51 RecombinaseSaccharomyces cerevisiaeCDC28 Protein Kinase, S cerevisiaeDNA, FungalDNA HelicasesProliferating Cell Nuclear AntigenRad51 RecombinaseSaccharomyces cerevisiae ProteinsSmall Ubiquitin-Related Modifier ProteinsSRS2 protein, S cerevisiae

Identifiers

PMID20195513
PMCPMC2829061
OpenAlexW1965675005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.